PR View by Helene Ellison

Share this article:
When pharmaceutical companies choose to maintain a favorable and high-profile media presence, the benefits are commercially advantageous, with measurable corporate, investor and marketing and sales impact.   

Today's media have become borderless in terms of global reach and access to information that can positively or negatively impact the international profile of a company, franchise or brand.  Recognizing that news coverage lives forever in archives and online, the role of influential third-party relationships provides an important way for pharma and biotech companies  to establish credibility and enhance corporate image. 

Companies that build strategic alliances with key opinion leaders and constituency groups have a means to ensure that information is delivered with medical value—and not left to the discretion of investors.  

Establishing a methodology for communications requires the formal alignment of internal and external stakeholder communications to support every milestone and event that can be leveraged to drive awareness of the value of a company and its portfolio.   

This requires: Systems for sharing all information about a brand and company with global team members who are integrated across all media, educational and promotional initiatives; collaboration with third parties to leverage earned media and advocacy on behalf of clinical trials, corporate announcements, patient testimonials, data results, publications, regulatory milestones, sponsorships and thought leader reactions to data; media and medical program tracking to make sure that brands are appropriately featured in all news and presentations; and proactive communications to maintain control over perception of corporate and brand news.

Helene Ellison is president and CEO of HealthSTAR PR
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.